By Fineline Cube 
Jiangxi Rimag Group Co., Ltd. (HKG: 2522) announced a Strategic Framework Cooperation Agreement with the Qingyang Municipal Government and its AI subsidiary, Shanghai Medical Image Insights Intelligent Technology Co., Ltd., to build a regional shared medical imaging center, an inter‑connected cloud platform, and a trusted health data space, advancing digital healthcare infrastructure in northwestern China.
Partnership Structure
| Item | Detail |
|---|---|
| Parent Company | Jiangxi Rimag Group Co., Ltd. (2522.HK) |
| Government Partner | Qingyang Municipal Government |
| Technology Partner | Shanghai Medical Image Insights Intelligent Technology (Rimag incubated AI subsidiary) |
| Agreement Type | Strategic Framework Cooperation Agreement |
| Geographic Focus | Qingyang region (Gansu Province) |
| Key Objectives | Shared imaging center, cloud index platform, trusted health data space |
Strategic Objectives
- Shared Medical Imaging Center: Establish a regional diagnostic hub providing standardized, high‑quality imaging services to local healthcare institutions, reducing duplication and improving access.
- Cloud Index Platform: Build an inter‑connected, interoperable, and mutually recognized imaging cloud enabling seamless data exchange and remote diagnostics across the region’s hospitals.
- Trusted Health Data Space: Create a secure, compliant data environment for medical informatization and AI‑driven analytics, supporting population health management.
Market Context & Outlook
| Metric | Value |
|---|---|
| China Medical Imaging AI Market | ¥12 billion (US$1.6 billion) in 2024 |
| Growth CAGR | 25% (2024‑2030) |
| Regional Healthcare Institutions | ~150 hospitals and clinics in Qingyang prefecture |
| Revenue Model | Imaging service fees, SaaS platform subscriptions, data analytics contracts |
| Peak Revenue Potential | ¥80‑120 million (US$11‑16 million) annually by 2028 |
- Competitive Edge: First government‑backed regional AI imaging platform in northwestern China; leverages Rimag’s incubated AI technology and public sector trust.
- Policy Alignment: Supports China’s “Healthy China 2030” and digital health infrastructure initiatives.
- Pipeline Expansion: Platform can scale to oncology screening and chronic disease management modules.
Forward‑Looking Statements
This brief contains forward‑looking statements regarding Rimag’s strategic partnership, platform development, and revenue potential. Actual results may differ materially due to risks including regulatory approval delays, technology integration challenges, and market adoption rates.-Fineline Info & Tech